Oncology practices are increasingly seeking ways to deliver expert, coordinated care outside the clinic – particularly between visits, when patients often face symptom flares, treatment concerns, or medication side effects. Principal Care Management (PCM) codes present a timely and powerful tool to capture reimbursement for this vital work. When coupled with remote care models supported by AI and guided by human oversight, PCM can strengthen patient outcomes, sustain clinic operations, and lay the groundwork for scalable innovation. Just as important, the policy environment signals that even more opportunities may be on the horizon.
What Are PCM Codes and Why They Matter in Oncology
PCM codes, created by Medicare, enable providers to bill for disease-specific management services for patients with a single high-risk chronic condition. Unlike Chronic Care Management (CCM), which requires two conditions, PCM recognizes that managing one serious illness (such as cancer) often demands significant ongoing support. The current codes (CPT 99424-99427) allow physicians and their teams to be reimbursed for care planning, ongoing coordination, medication and symptom monitoring, and other non-face-to-face work that so often defines the oncology patient journey.
For oncologists, this is a game changer. So much of cancer care occurs between appointments: managing nausea or fatigue, arranging lab work, adjusting medications, or clarifying treatment instructions. PCM acknowledges this reality by reimbursing providers for services that help patients avoid deterioration, complications, or unnecessary emergency visits.
Remote Care and AI: Extending the Reach of PCM
The potential of PCM grows when paired with remote cancer care. Virtual check-ins, secure messaging, and symptom monitoring tools allow clinicians to stay connected with patients in real time, rather than waiting for the next office visit. AI can further amplify this reach by triaging patient-reported issues, generating reminders, or flagging concerning patterns for review — while the care team maintains ultimate oversight. This human-in-the-loop approach ensures patients benefit from the efficiency of technology without losing the safety and trust that come from clinical judgment.
Consider a patient reporting new shortness of breath through a remote symptom tracker. AI can categorize the concern, prompt immediate outreach, and log the episode in the care plan. A nurse or physician then reviews and decides whether an urgent visit, medication adjustment, or reassurance is most appropriate. That combination of speed, accuracy, and human oversight embodies the promise of PCM in oncology.
Meeting Requirements and Unlocking Reimbursement
To qualify for PCM billing, patients must have a single serious chronic condition expected to last at least three months, consent must be obtained and documented, and clinicians must spend at least 30 minutes per month engaged in care management tasks. For oncology patients, those thresholds are not only achievable but often already part of routine workflows. By carefully documenting activities such as medication management, care coordination, and patient follow-ups, providers can capture reimbursement for work that previously went uncompensated.
Payment levels vary, but current reimbursement rates hover around $80-$85 per month for the initial 30 minutes of physician or qualified professional time, with additional codes for longer engagements or staff-directed care. When multiplied across patient panels, these payments can represent a meaningful revenue stream while ensuring that practices remain sustainable in delivering comprehensive cancer care.
Policy Momentum and Future Directions
The significance of PCM goes beyond the codes themselves. Policymakers have shown a willingness to expand reimbursement for remote and tech-enabled care, including Remote Patient Monitoring (RPM) and Remote Therapeutic Monitoring (RTM). Medicare’s annual Physician Fee Schedule rulemaking has repeatedly signaled interest in new models that recognize the value of non-face-to-face, digitally supported care. Advocacy groups are pushing for broader eligibility, streamlined documentation, and better integration with Medicare Advantage and commercial payers. The trajectory suggests that PCM is only the beginning, with additional codes and programs likely to follow as the healthcare system shifts toward value-based, patient-centered models.
Key Takeaways
For oncology practices, PCM codes represent a rare alignment of patient need, clinical best practice, and financial sustainability. They allow providers to capture reimbursement for essential services they already perform, while remote care and AI technologies expand capacity and responsiveness. Human-in-the-loop AI ensures that efficiency never comes at the expense of patient trust or safety.
As new reimbursement pathways emerge, oncology providers have an opportunity to stay ahead by building PCM-compatible workflows today. Doing so will not only improve patient experiences and outcomes, but also prepare practices to take advantage of future codes and payment models that continue to recognize the critical role of remote, technology-enabled cancer care.